Buyout framework
I was wondering if anyone here has much experience with what exactly the process would be if Ifenprodil does reach statistical significance and companies started making offers? What exactly would happen to share structure? Would it be a buyout, or partnership, and would the other ipf/chronic cough trial be effected from a shareholder perspective?